Skip to main content

Table 2 Complete protection among enrolled patients (n = 329)

From: The effectiveness of NEPA in the prevention of chemotherapy-induced nausea vomiting among chemo naive patients in an Indian setting

Phases Complete protection (%)
Enrolled patients (n = 329) HEC (n = 260) MEC (n = 69)
Acute phase 88.44 85.76 98.55
Delayed phase 81.76 81.15 84.05
Overall phase 80.54 79.61 84.05